Malady Kyle
- SEC CIK
- 0001760581
In the past year, 13 open-market sale filings worth $672.7K and no purchases.
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $672.7K
- 13 filings
- Net
- −$672.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Malady Kyle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VZ Verizon Communications Inc
EVP and Group CEO-VZ Business27 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2026 (view filing)1:30 PM ET | Nov 10 | 2 days | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $46.11 | −$50.7K | −1.1%96.7K after | 10b5-1 |
| Nov 4, 2026 (view filing)3:15 PM ET | Nov 3 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $44.79 | −$49.3K | −1.1%97.8K after | 10b5-1 |
| Oct 28, 2026 (view filing)12:38 PM ET | Oct 27 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $43.00 | −$47.3K | −1.1%98.9K after | 10b5-1 |
| Oct 21, 2026 (view filing)3:08 PM ET | Oct 20 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $44.48 | −$48.9K | −1.1%100.0K after | 10b5-1 |
| Oct 14, 2026 (view filing)2:00 PM ET | Oct 13 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $42.93 | −$47.2K | −1.1%101.1K after | 10b5-1 |
| Oct 7, 2026 (view filing)2:25 PM ET | Oct 6 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $45.75 | −$50.3K | −1.1%102.2K after | 10b5-1 |
| Sep 30, 2026 (view filing)2:03 PM ET | Sep 29 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $46.40 | −$51.0K | −1.1%103.3K after | 10b5-1 |
| Sep 23, 2026 (view filing)1:48 PM ET | Sep 22 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $47.65 | −$52.4K | −1.0%104.4K after | 10b5-1 |
| Sep 16, 2026 (view filing)3:43 PM ET | Sep 15 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $51.19 | −$56.3K | −1.0%105.5K after | 10b5-1 |
| Sep 9, 2026 (view filing)1:40 PM ET | Sep 8 | 1 day | Malady KyleEVP and Group CEO-VZ Business | SSale | −1.10K | $49.98 | −$55.0K | −1.0%106.6K after | 10b5-1 |
DXCM Dexcom Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 (view filing) | Sep 5 | 4 days | Malady KyleDirector | SSale | −667 | $80.86 | −$53.9K | −2.9%22.7K after | 10b5-1 |